Clene Inc. (CLNN) major holder sells 39,162 common shares

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Clene Inc. ten percent owner Ugwumba Chidozie, through SymBiosis II, LLC, reported open-market sales of Clene common stock over three days. SymBiosis II, LLC sold 6,374 shares at $6.48 on April 15, 7,748 shares at $6.40 on April 16, and 25,040 shares at $6.43 on April 17, leaving 362,729 shares of indirect ownership after the latest transaction.

Insider Trade Summary

Net Seller: 39,162 shares ($251,898)

Net Sell 3 txns

Insider Ugwumba Chidozie

Role 10% Owner

Sold 39,162 shs ($252K)

Type	Security	Shares	Price	Value
Sale	Common Stock	25,040	$6.43	$161K
Sale	Common Stock	7,748	$6.40	$50K
Sale	Common Stock	6,374	$6.48	$41K

Holdings After Transaction: Common Stock — 362,729 shares (Indirect, By SymBiosis II, LLC)

Footnotes (1)

Key Figures

Shares sold 2026-04-15: 6,374 shares at $6.48 Shares sold 2026-04-16: 7,748 shares at $6.40 Shares sold 2026-04-17: 25,040 shares at $6.43 +2 more

5 metrics

Shares sold 2026-04-15 6,374 shares at $6.48 Open-market sale of common stock, indirect ownership by SymBiosis II, LLC

Shares sold 2026-04-16 7,748 shares at $6.40 Open-market sale of common stock, indirect ownership by SymBiosis II, LLC

Shares sold 2026-04-17 25,040 shares at $6.43 Open-market sale of common stock, indirect ownership by SymBiosis II, LLC

Total shares sold 39,162 shares Aggregate of three open-market sales reported in Form 4

Shares held after latest sale 362,729 shares Indirect holdings by SymBiosis II, LLC following April 17, 2026 trade

Key Terms

open-market sale, ten percent owner, indirect ownership, Common Stock

4 terms

open-market sale financial

"transaction_action: "open-market sale" for each non-derivative trade"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner financial

"reporting person flagged as "is_ten_percent_owner": 1"

indirect ownership financial

"ownership_type: "indirect" and nature_of_ownership: "By SymBiosis II, LLC""

Common Stock financial

"security_title: "Common Stock" for all reported transactions"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 08:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last)

(First)

(Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE

ARKANSAS

72712

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/15/2026		S		6,374	D	$6.48	395,517	I	By SymBiosis II, LLC
Common Stock	04/16/2026		S		7,748	D	$6.4	387,769	I	By SymBiosis II, LLC
Common Stock	04/17/2026		S		25,040	D	$6.43	362,729	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Chidozie Ugwumba	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did CLNN report for Ugwumba Chidozie?

Clene Inc. reported that ten percent owner Ugwumba Chidozie, through SymBiosis II, LLC, sold common stock in three open-market transactions. These occurred on April 15, 16, and 17, 2026, and together reduced the LLC’s indirect holdings while leaving a substantial remaining position.

How many Clene (CLNN) shares were sold in the latest Form 4?

The Form 4 shows total sales of 39,162 Clene common shares by SymBiosis II, LLC. The transactions were 6,374 shares on April 15, 7,748 shares on April 16, and 25,040 shares on April 17, all reported as open-market sales of indirectly held shares.

At what prices were CLNN shares sold in these insider transactions?

SymBiosis II, LLC sold Clene common stock at three prices: $6.48 per share on April 15, $6.40 per share on April 16, and $6.43 per share on April 17, 2026. Each trade was reported as a non-derivative open-market sale of common stock.

How many CLNN shares does the reporting person still hold after these sales?

After the April 17, 2026 transaction, SymBiosis II, LLC held 362,729 Clene common shares indirectly attributed to ten percent owner Ugwumba Chidozie. This figure reflects the position following the last reported open-market sale in the Form 4 filing data.

Are the CLNN insider sales direct or indirect holdings of Ugwumba Chidozie?

The reported CLNN sales involve indirect holdings. All three transactions are coded as indirect ownership, with the nature of ownership described as “By SymBiosis II, LLC,” meaning the trades were executed by that entity associated with ten percent owner Ugwumba Chidozie.

What type of transactions were reported in the CLNN Form 4 filing?

All reported trades in the CLNN Form 4 are non-derivative open-market sales of common stock. Each is coded with transaction code “S” and described as a sale in open market or private transaction, with no derivative exercises or gifts disclosed in the data.